Lewes, DE -- (SBWIRE) -- 09/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: FUSE SCIENCE, INC(OTCMKTS:DROP), Minerco Resources Inc(OTCMKTS:MINE), Advaxis, Inc.(OTCBB:ADXS), CHINA CONSTRUCTION B(OTCMKTS:CICHY).
FUSE SCIENCE, INC(OTCMKTS:DROP) ended lower -2.21% and complete the day at $0.0665. The total number of shares changed hands during the day was5.23 million. After opening at $0.07, the stock hit as high as $0.08. However, it traded between $0.06 and $0.28 over the last twelve months.
Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields. Its delivery systems include sublingual and transdermal delivery technologies that enable energy, medicines, vitamins, and minerals to bypass the gastrointestinal tract and enter the blood stream directly.
Has DROP Found The Bottom and Ready To Move Up? Find Out Here
Minerco Resources Inc(OTCMKTS:MINE) closed yesterday at $0.0059, a +9.26% increase. Around 76.74 million shares were traded, beating an-average trading volume of 46.44 million shares. The company is now valued at around $5.84 million.
Minerco Resources, Inc., a development stage company, engages in the development, production, and provision of clean, renewable energy solutions in Central America. It owns 100% interests in the 6 mega-watts per hour Chiligatoro hydro-electric project located in Intibuca,
For How Long MINE Gloss will Attract Investors? Find out via this report
Advaxis, Inc.(OTCBB:ADXS) moved +23.90 percent higher at $5.08 and traded between $4.29 and $5.45 after opening the day at $4.40. Its performance over the last five days remained 20.95%, which stands at 60.25% for a month. Going back further than one month, 1-year performance after recent close was 35.47%.
Advaxis, Inc., a clinical development stage biotechnology company, engages in the development of immunotherapies for cancer and infectious diseases. The company?s platform technology generates an immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor.
For How Long ADXS Gloss will Attract Investors? Find out via this report
CHINA CONSTRUCTION B(OTCMKTS:CICHY) shares rose, gaining +1.36 percent to close at $15.66. The stock is down around -3.51% this year and 20.37% for the last 12 months. Around 108,815 shares changed hands yesterday, higher from an-average trading volume of 84,507 shares.
China Construction Bank Corporation, together with its subsidiaries, provides corporate and personal banking, and treasury services. Its Corporate Banking segment offers various financial products and services to corporations, government agencies, and financial institutions.
Why Should Investors Buy CICHY After The Recent Gain? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/